BIOGEN PHARMACHEM INDUSTRIES L
Latest filings
Next results: Tue, 3 Nov · Financial Results- Board to approve Q2 and half-year results on 3 November 2026 · Results
- Non-promoter shareholder exits Biogen with a 4.04% stake sale · Ownership Changes
- RTA compliance certificate filed for Q2 FY27, no physical share certificates received · Compliance
Snapshot
What the business is, and whether it's a good one at a fair price.
A Finance company listed on BSE, reporting revenue of ₹1 Cr over the trailing twelve months.
Scorecard
Measured from the filed financials, judged against its Other Financial Services peers · as of FY26 — not investment advice
Strengths
Concerns
Charts
How has the market priced it — with filings on the timeline?
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from BIOGEN PHARMACHEM INDUSTRIES L's filed financials and exchange disclosures
What does BIOGEN PHARMACHEM INDUSTRIES L do?
BIOGEN PHARMACHEM INDUSTRIES L is a Finance company listed on BSE.
Is BIOGEN PHARMACHEM INDUSTRIES L profitable?
No. Over the trailing twelve months BIOGEN PHARMACHEM INDUSTRIES L reported a net loss of ₹0.17 Cr on revenue of ₹1.02 Cr.
Does BIOGEN PHARMACHEM INDUSTRIES L pay a dividend?
Not in the latest reported year — BIOGEN PHARMACHEM INDUSTRIES L's dividend payout for FY26 was nil.
Is BIOGEN PHARMACHEM INDUSTRIES L debt-free?
Yes. It reported no borrowings on its 31 Mar 2026 balance sheet, and ₹0.32 Cr of cash.
Is BIOGEN PHARMACHEM INDUSTRIES L expensive compared with its peers?
On trailing P/E, BIOGEN PHARMACHEM INDUSTRIES L ranks 24 of 76 in Other Financial Services — cheaper than 69% of them, against an industry median of 19.0×. This is a position, not a valuation judgement.
How much does the BIOGEN PHARMACHEM INDUSTRIES L share price move in a day?
On a typical session BIOGEN PHARMACHEM INDUSTRIES L moves 1.69% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.
When are BIOGEN PHARMACHEM INDUSTRIES L's next results?
Financial Results on Tue, 3 Nov. MarketPing alerts you on WhatsApp the moment the filing lands.
Where can I track BIOGEN PHARMACHEM INDUSTRIES L's announcements?
Every NSE and BSE filing by BIOGEN PHARMACHEM INDUSTRIES L appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.